Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10601 - 10608 of 12008 results
Our Law360 Article Analyzing CPSC's Proposal to Expand Disclosure of Company & Product Information
February 27, 2014| Blog| Viewpoint
Unprecedented HIPAA Fine May Mean Increased Scrutiny and Penalties
February 26, 2014| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Reform Update on February 24, 2014
February 26, 2014| Blog| Viewpoint
SEC Approves Revised Semi-Annual Data Reporting Requirements for Section 529 Plan Underwriters
February 26, 2014| Blog| Viewpoint
The SEC Speaks About FCPA
February 25, 2014| Blog| Viewpoint
En Español: HHS Agencies Issue Model Notices of Privacy Practices in Spanish
February 24, 2014| Blog| Viewpoint
The Top 10 Changes Made to the 2012 Proposed Rule Under the Affordable Care Act’s Employer Shared Responsibility Rules by Recently Issued Final Regulations
February 24, 2014| Advisory| Viewpoint
NLRB Still Looking for Answers On Whether University Faculty Are “Managerial Employees”
February 24, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|